{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:48:49Z","timestamp":1786992529749,"version":"build-2736575974"},"reference-count":238,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jhepr.2023.100965","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T17:54:23Z","timestamp":1700157263000},"page":"100965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Transplant oncology \u2013 Current indications and strategies to advance the field"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-490X","authenticated-orcid":false,"given":"Felix J.","family":"Krendl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-0794","authenticated-orcid":false,"given":"Ruben","family":"Bellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Scheidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Margreiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Oberhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1479-6129","authenticated-orcid":false,"given":"Manuel","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100965_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01656377","article-title":"Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy","volume":"6","author":"Iwatsuki","year":"1982","journal-title":"World J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/TP.0000000000003175","article-title":"The ILTS consensus conference on transplant oncology: setting the stage","volume":"104","author":"Sapisochin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4254\/wjh.v7.i15.1899","article-title":"Selection tool alpha-fetoprotein for patients waiting for liver transplantation: how to easily manage a fractal algorithm","volume":"7","author":"Lai","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib4","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","article-title":"Liver transplantation for hepatocellular carcinoma. Working group report from the ILTS transplant oncology consensus conference","volume":"104","author":"Mehta","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/TP.0000000000003118","article-title":"Liver transplantation for colorectal and\u00a0neuroendocrine liver metastases and hepatoblastoma. Working group report from the ILTS transplant oncology consensus conference","volume":"104","author":"Hibi","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","article-title":"Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS transplant oncology consensus conference","volume":"104","author":"Sapisochin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194911","article-title":"Transplant oncology: an evolving field in cancer care","volume":"13","author":"Abdelrahim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib8","first-page":"98","article-title":"Pro (with caution): extended oncologic indications in liver transplantation","volume":"24","author":"Mazzaferro","year":"2018","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib9","first-page":"659","article-title":"Homotransplantation of the liver in humans","volume":"117","author":"Starzl","year":"1963","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jhepr.2023.100965_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.surg.2018.10.024","article-title":"What is transplant oncology?","volume":"165","author":"Hibi","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jhepr.2023.100965_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/SLA.0000000000004071","article-title":"Transplant oncology in primary\u00a0and\u00a0metastatic liver tumors: principles, evidence, and opportunities","volume":"273","author":"Sapisochin","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00000658-199109000-00005","article-title":"Hepatic resection versus transplantation for hepatocellular carcinoma","volume":"214","author":"Iwatsuki","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/bmj.283.6284.115","article-title":"Improved survival after orthotopic liver grafting","volume":"283","author":"Calne","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jhepr.2023.100965_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/hep.1840020516","article-title":"Evolution of liver transplantation","volume":"2","author":"Starzl","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1151::AID-CNCR8>3.0.CO;2-V","article-title":"Should hepatomas be treated with hepatic resection or transplantation?","volume":"86","author":"Yamamoto","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib16","first-page":"1567","article-title":"Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?","volume":"23","author":"M\u00fchlbacher","year":"1991","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhepr.2023.100965_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.tp.0000189711.98971.9c","article-title":"Genetic detection of lymph node micrometastases: a selection criterion for liver transplantation in patients with liver metastases after colorectal cancer","volume":"81","author":"Kappel","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib18","first-page":"305","article-title":"[Our therapy concept in nonresectable liver metastases]","volume":"138","author":"Margreiter","year":"1988","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jhepr.2023.100965_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the\u00a0treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5662\/wjm.v12.i1.32","article-title":"Liver transplant allocation policies and outcomes in United States: a comprehensive review","volume":"12","author":"Latt","year":"2022","journal-title":"World J Methodol"},{"key":"10.1016\/j.jhepr.2023.100965_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40472-016-0117-6","article-title":"Liver-allocation policies for patients affected by HCC in Europe","volume":"3","author":"De Carlis","year":"2016","journal-title":"Curr Transpl Rep"},{"key":"10.1016\/j.jhepr.2023.100965_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","article-title":"Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA","volume":"246","author":"Duffy","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000343832","article-title":"Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies","volume":"1","author":"Lee Cheah","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/SLA.0000000000002964","article-title":"Is it time to abandon the Milan criteria?: results of a bicoastal US collaboration to redefine hepatocellular carcinoma liver transplantation selection policies","volume":"268","author":"Halazun","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112662","article-title":"Liver transplant oncology: towards dynamic tumor-biology-oriented patient selection","volume":"14","author":"Ilmer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2016.10.008","article-title":"Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics","volume":"66","author":"Bhat","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib27","first-page":"1023","article-title":"The intention-to-treat effect of bridging treatments in the setting of Milan criteria-in patients waiting for liver transplantation","volume":"25","author":"Lai","year":"2019","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00595-016-1337-1","article-title":"Liver transplantation for hepatobiliary malignancies: a new era of \u201cTransplant Oncology\u201d has begun","volume":"47","author":"Hibi","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.jhepr.2023.100965_bib29","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib30","first-page":"57","article-title":"[Indications for liver transplantation in neoplasms of the liver]","volume":"20","author":"Stauber","year":"1993","journal-title":"Acta Med Austriaca"},{"key":"10.1016\/j.jhepr.2023.100965_bib31","first-page":"104","article-title":"Con: liver transplantation for expanded criteria malignant diseases","volume":"24","author":"Schaefer","year":"2018","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/gut.2007.131730","article-title":"Selection of patients for liver transplantation and allocation of donated livers in the UK","volume":"57","author":"Neuberger","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100965_bib33","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1002\/lt.20247","article-title":"Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era","volume":"10","author":"Olthoff","year":"2004","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1600-6143.2007.02138.x","article-title":"A\u00a0novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria","volume":"8","author":"Volk","year":"2008","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100965_bib37","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s13304-021-01078-4","article-title":"Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score","volume":"73","author":"Lerut","year":"2021","journal-title":"Updates Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.suronc.2019.10.006","article-title":"Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium","volume":"33","author":"Degroote","year":"2020","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","article-title":"Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma","volume":"154","author":"Mazzaferro","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100965_bib42","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.30413","article-title":"Alpha-fetoprotein decrease from >1,000 to <500 ng\/ml in patients with hepatocellular carcinoma leads to improved posttransplant outcomes","volume":"69","author":"Mehta","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib43","article-title":"National experience on waitlist outcomes for down-staging of hepatocellular carcinoma: high dropout rate in \u201cAll-Comers","author":"Huang","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5009\/gnl19265","article-title":"Expanding indications for liver transplant: tumor and patient factors","volume":"15","author":"Chu","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2023.100965_bib45","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2006-947295","article-title":"Expanded criteria for hepatocellular carcinoma: down-staging with a view to liver transplantation--yes","volume":"26","author":"Yao","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100965_bib47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/hep.29342","article-title":"Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib48","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100965_bib49","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1097\/TP.0000000000001402","article-title":"Predictors of successful downstaging of hepatocellular carcinoma outside Milan criteria","volume":"100","author":"Murali","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10333","article-title":"Patient selection for downstaging of hepatocellular carcinoma prior to liver transplantation-adjusting the odds?","volume":"35","author":"Seehofer","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib51","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.30570","article-title":"Are there upper limits in tumor burden for down-staging of hepatocellular carcinoma to liver transplant? Analysis of the all-comers protocol","volume":"70","author":"Sinha","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib52","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/lt.20526","article-title":"A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation","volume":"11","author":"Yao","year":"2005","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib53","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2021.07.033","article-title":"Downstaging outcomes for hepatocellular carcinoma: results from the multicenter evaluation of reduction in tumor size before liver transplantation (MERITS-LT) consortium","volume":"161","author":"Mehta","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100965_bib54","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1470-2045(20)30224-2","article-title":"Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b\/3 trial","volume":"21","author":"Mazzaferro","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fonc.2020.00381","article-title":"Pulmonary resection for metastasis of hepatocellular carcinoma recurring after liver transplant: an Italian multicenter experience","volume":"10","author":"Invenizzi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archsurg.2007.39","article-title":"Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators","volume":"143","author":"Zimmerman","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaoncol.2016.5116","article-title":"Validation of a risk estimation of tumor recurrence after transplant (RETREAT) score for hepatocellular carcinoma recurrence after liver transplant","volume":"3","author":"Mehta","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib58","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/ajt.14549","article-title":"Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database","volume":"18","author":"Mehta","year":"2018","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030630","article-title":"External validation of the RETREAT score for prediction of hepatocellular carcinoma recurrence after liver transplantation","volume":"14","author":"van Hooff","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib60","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1245\/s10434-014-4273-6","article-title":"Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series","volume":"22","author":"Sapisochin","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib61","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.3748\/wjg.v21.i39.11185","article-title":"Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review","volume":"21","author":"de\u2019Angelis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100965_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0000000000001894","article-title":"Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation: impact of treatment modality and recurrence characteristics","volume":"266","author":"Bodzin","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transplant"},{"key":"10.1016\/j.jhepr.2023.100965_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100965_bib65","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s11605-020-04721-4","article-title":"Liver transplantation for peri-hilar cholangiocarcinoma","volume":"24","author":"Tan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib66","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhepr.2023.100965_bib67","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/TP.0000000000003114","article-title":"Neoadjuvant chemoradiotherapy and liver transplantation for unresectable hilar cholangiocarcinoma: the Irish experience of the Mayo protocol","volume":"104","author":"Zaborowski","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/SLA.0000000000003801","article-title":"Meta-analysis and meta-regression of survival after liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"273","author":"Cambridge","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib69","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib70","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhepr.2023.100965_bib71","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00268-019-04966-4","article-title":"Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival","volume":"43","author":"Wu","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2023.100965_bib74","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ajt.12591","article-title":"\u201cVery early\u201d intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?","volume":"14","author":"Sapisochin","year":"2014","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib75","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \u201cvery early\u201d intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10802","article-title":"Outcomes after liver transplantation with incidental cholangiocarcinoma","volume":"35","author":"Safdar","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib77","article-title":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma","author":"Alvaro","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib78","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib79","article-title":"Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma","author":"McMillan","year":"2021","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MOT.0000000000000618","article-title":"Contemporary management of hepatoblastoma","volume":"24","author":"Hafberg","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.jhepr.2023.100965_bib81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21037\/tgh.2016.04.01","article-title":"Pediatric liver transplantation for hepatoblastoma","volume":"1","author":"Trobaugh-Lotrario","year":"2016","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib82","article-title":"Recent advances in surgical strategies and liver transplantation for hepatoblastoma","author":"Honda","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib83","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.3748\/wjg.v20.i18.5331","article-title":"Liver transplantation for malignancy: current treatment strategies and future perspectives","volume":"20","author":"Hackl","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100965_bib84","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MOP.0000000000000081","article-title":"Management of hepatoblastoma: an update","volume":"26","author":"Kremer","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jhepr.2023.100965_bib85","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","article-title":"2017 PRETEXT: radiologic\u00a0staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)","volume":"48","author":"Towbin","year":"2018","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jhepr.2023.100965_bib86","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/ajt.16945","article-title":"Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: experience from the Society of Pediatric Liver Transplantation (SPLIT)","volume":"22","author":"Boster","year":"2022","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib87","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-200201150-00017","article-title":"Living-related liver transplantation and vena cava reconstruction after total hepatectomy including the vena cava for hepatoblastoma","volume":"73","author":"Chardot","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27383","article-title":"Surgical treatment strategy for advanced hepatoblastoma: resection versus transplantation","volume":"65","author":"Uchida","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13113","article-title":"Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: a single-institute experience","volume":"22","author":"Umeda","year":"2018","journal-title":"Pediatr Transpl"},{"key":"10.1016\/j.jhepr.2023.100965_bib91","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/tri.13924","article-title":"An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan","volume":"34","author":"Uchida","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib92","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.ejso.2019.07.024","article-title":"Liver transplantation for unresectable malignancies: beyond hepatocellular carcinoma","volume":"45","author":"Amer","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib93","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/cncr.33751","article-title":"Liver transplantation for hepatic epithelioid hemangioendothelioma","volume":"127","author":"Merriam","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib94","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(06)70697-0","article-title":"Spontaneous complete regression of hepatic epithelioid haemangioendothelioma","volume":"7","author":"Otrock","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hbpd.2019.11.006","article-title":"Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014","volume":"19","author":"Noh","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib96","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1477-2574.2010.00213.x","article-title":"Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option?","volume":"12","author":"Grotz","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhepr.2023.100965_bib97","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jso.24979","article-title":"Primary liver sarcomas in the modern era: resection or transplantation?","volume":"117","author":"Konstantinidis","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib98","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/TP.0000000000002982","article-title":"Liver transplantation for hepatic epithelioid hemangioendothelioma is facilitated by exception points with acceptable long-term outcomes","volume":"104","author":"Brahmbhatt","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib99","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/SLA.0b013e31815c2a70","article-title":"The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry","volume":"246","author":"Lerut","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11605-007-0247-3","article-title":"Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005","volume":"12","author":"Rodriguez","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib101","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1155\/2008\/418485","article-title":"Liver transplantation for hepatic epithelioid hemangioendothelioma: the Canadian multicentre experience","volume":"22","author":"Nudo","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100965_bib102","series-title":"Guidance to liver transplant programs and the national liver review board for: adult MELD exception review","year":"2022"},{"key":"10.1016\/j.jhepr.2023.100965_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5858\/arpa.2016-0171-RS","article-title":"Hepatic epithelioid hemangioendothelioma","volume":"142","author":"Studer","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib104","article-title":"New insights into the pathophysiology and clinical care of rare primary liver cancers","volume":"3","author":"Gigante","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100965_bib105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/TP.0000000000001603","article-title":"Hepatic epithelioid hemangioendothelioma and adult liver transplantation: proposal for a prognostic score based on the analysis of the ELTR-ELITA registry","volume":"101","author":"Lai","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib106","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1378\/chest.11-0039","article-title":"Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer","volume":"140","author":"Lau","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.jhepr.2023.100965_bib107","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1111\/ajt.13430","article-title":"Combined or serial liver and lung transplantation for epithelioid hemangioendothelioma: a case series","volume":"15","author":"Desie","year":"2015","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2023.100965_bib109","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","article-title":"Colorectal cancer","volume":"383","author":"Brenner","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.jhepr.2023.100965_bib110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12885-017-3925-x","article-title":"Colorectal cancer liver metastases - a population-based study on incidence, management and survival","volume":"18","author":"Engstrand","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib111","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1186\/1471-2407-14-810","article-title":"Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma","volume":"14","author":"Hackl","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib112","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36666","article-title":"Incidence and survival in synchronous and metachronous liver metastases from colorectal cancer","volume":"5","author":"Reboux","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhepr.2023.100965_bib113","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution","volume":"210","author":"House","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib114","first-page":"20","article-title":"New paradigm in the management of liver-only metastases from colorectal cancer","volume":"1","author":"Donadon","year":"2007","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.jhepr.2023.100965_bib115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.sla.0000138076.72547.b1","article-title":"Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)","volume":"240","author":"Fernandez","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib116","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib117","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/SLA.0000000000000786","article-title":"Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer?","volume":"261","author":"Dueland","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/bjs.10651","article-title":"Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases","volume":"105","author":"Grut","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib119","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijsu.2020.03.079","article-title":"Liver transplantation for colorectal liver metastases: what do we need to know?","volume":"82","author":"Line","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1432-2277.2008.00735.x","article-title":"Liver transplantation for primary and metastatic liver cancers","volume":"21","author":"Hoti","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib121","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.jhepr.2023.100965_bib122","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/cncr.34170","article-title":"A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer","volume":"128","author":"Lebeck Lee","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib123","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.5306\/wjco.v12.i12.1193","article-title":"Role of liver transplantation in the management of colorectal liver metastases: challenges and opportunities","volume":"12","author":"Tasoudis","year":"2021","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SLA.0000000000003404","article-title":"Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases","volume":"271","author":"Dueland","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib125","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.2932","article-title":"Long-term survival, prognostic factors, and selection of patients with colorectal cancer for liver transplant: a nonrandomized controlled trial","author":"Dueland","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib126","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0267","article-title":"Survival outcomes after portal vein embolization and liver resection compared with liver transplant for patients with extensive colorectal cancer liver metastases","author":"Dueland","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib127","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/tri.13981","article-title":"Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score","volume":"34","author":"Lanari","year":"2021","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib128","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2468-1253(21)00219-3","article-title":"Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines","volume":"6","author":"Bonney","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib129","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/bjs5.50278","article-title":"Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study)","volume":"4","author":"Smedman","year":"2020","journal-title":"BJS Open"},{"key":"10.1016\/j.jhepr.2023.100965_bib130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jhepr.2023.100965_bib131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11605-018-3973-9","article-title":"Liver resection for neuroendocrine tumor liver metastases within Milan criteria for liver transplantation","volume":"23","author":"Ruzzenente","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib132","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11154-017-9439-7","article-title":"The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons","volume":"18","author":"Sposito","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jhepr.2023.100965_bib133","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/ajt.17156","article-title":"Long-term outcomes of resection versus transplantation for neuroendocrine liver metastases meeting the Milan criteria","volume":"22","author":"Maspero","year":"2022","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib134","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000443167","article-title":"ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site","volume":"103","author":"Pavel","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jhepr.2023.100965_bib136","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1245\/s10434-017-5839-x","article-title":"Management of neuroendocrine tumor liver metastases: long-term outcomes and prognostic factors from a large prospective database","volume":"24","author":"Fairweather","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib137","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.28760","article-title":"Therapeutic strategies for neuroendocrine liver metastases","volume":"121","author":"Frilling","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2023.100965_bib138","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/ajt.13831","article-title":"The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors","volume":"16","author":"Mazzaferro","year":"2016","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib139","doi-asserted-by":"crossref","first-page":"678392","DOI":"10.3389\/fsurg.2021.678392","article-title":"Rare malignant indications for liver transplantation: a collaborative transplant study report","volume":"8","author":"Houben","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib140","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhep.2007.07.004","article-title":"Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?","volume":"47","author":"Mazzaferro","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib141","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11912-022-01343-8","article-title":"Where are we now with liver transplantation in neuroendocrine neoplasms? The place of liver transplantation for Grades 1 and 2 well-differentiated unresectable liver metastatic neuroendocrine tumours","volume":"25","author":"Shah","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jhepr.2023.100965_bib142","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000479293","article-title":"Morphological and functional imaging for detecting and assessing the resectability of neuroendocrine liver metastases","volume":"106","author":"Ronot","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jhepr.2023.100965_bib143","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2016.06.024","article-title":"Functional imaging in liver tumours","volume":"65","author":"Ronot","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib144","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/j.semnuclmed.2011.02.001","article-title":"(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives","volume":"41","author":"Breeman","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archsurg.2011.186","article-title":"Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database","volume":"146","author":"Gedaly","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib146","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study","volume":"257","author":"Le Treut","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib147","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.gassur.2003.11.010","article-title":"Liver transplantation for neuroendocrine tumors","volume":"8","author":"Florman","year":"2004","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib148","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/lt.20755","article-title":"Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients","volume":"12","author":"Frilling","year":"2006","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib149","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2008.02233.x","article-title":"Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report","volume":"8","author":"Le Treut","year":"2008","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib150","doi-asserted-by":"crossref","first-page":"742890","DOI":"10.4061\/2011\/742890","article-title":"Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience","volume":"2011","author":"Nguyen","year":"2011","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jso.23973","article-title":"Liver transplantation for metastatic neuroendocrine tumors: outcomes and prognostic variables","volume":"112","author":"Sher","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib152","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/lt.21056","article-title":"Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors","volume":"13","author":"Olausson","year":"2007","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib153","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.transproceed.2019.04.010","article-title":"Liver transplant for metastatic neuroendocrine tumors: a single-center experience in Hungary","volume":"51","author":"Korda","year":"2019","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhepr.2023.100965_bib154","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/TP.0000000000003802","article-title":"Postrecurrence survival after liver transplantation for liver metastases from neuroendocrine tumors","volume":"105","author":"Sposito","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib155","article-title":"Controversy over liver transplantation or resection for neuroendocrine liver metastasis: tumor biology cuts the deal","author":"Eshuminov","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib156","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib157","volume":"9","author":"de Vries","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2023.100965_bib158","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2023.100965_bib159","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/TP.0000000000003296","article-title":"Clinical implementation of prolonged liver preservation and monitoring through normothermic machine perfusion in liver transplantation","volume":"104","author":"Cardini","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/SLA.0000000000001473","article-title":"First comparison of hypothermic oxygenated perfusion versus static cold storage of human donation after cardiac death liver transplants: an international-matched case analysis","volume":"262","author":"Dutkowski","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib161","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41467-020-16251-3","article-title":"Transplantation of discarded\u00a0livers following viability testing with normothermic machine perfusion","volume":"11","author":"Mergental","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100965_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.17022","article-title":"Sequential hypothermic and normothermic machine perfusion enables safe transplantation of high-risk donor livers","author":"van Leeuwen","year":"2022","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib163","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","article-title":"Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial","volume":"270","author":"van Leeuwen","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib164","first-page":"367","article-title":"Reduced-sized orthotopic liver graft in hepatic transplantation in children","volume":"95","author":"Bismuth","year":"1984","journal-title":"Surgery"},{"key":"10.1016\/j.jhepr.2023.100965_bib165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01262776","article-title":"Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation","volume":"373","author":"Pichlmayr","year":"1988","journal-title":"Langenbecks Arch Chir"},{"key":"10.1016\/j.jhepr.2023.100965_bib166","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.sla.0000189120.62975.0d","article-title":"Technical refinements and results in full-right full-left splitting of the deceased donor liver","volume":"242","author":"Broering","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib167","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jhep.2022.07.035","article-title":"Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: international multicenter analysis of the US, the UK, and Canada","volume":"77","author":"Ivanics","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib168","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1600-6143.2004.00522.x","article-title":"Allograft survival following adult-to-adult living donor liver transplantation","volume":"4","author":"Abt","year":"2004","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib169","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/lt.20254","article-title":"Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation","volume":"10","author":"Thuluvath","year":"2004","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib170","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMsa021345","article-title":"A survey of liver transplantation from living adult donors in the United States","volume":"348","author":"Brown","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib171","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1053\/j.gastro.2008.02.092","article-title":"Live donors in liver transplantation","volume":"134","author":"Brown","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100965_bib172","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-med-051517-125454","article-title":"Current status of living donor liver transplantation in the United States","volume":"70","author":"Abu-Gazala","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib173","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/SLA.0000000000003463","article-title":"Adult living donor versus deceased donor liver transplant (LDLT versus DDLT) at a single center: time to change our paradigm for liver transplant","volume":"270","author":"Humar","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib174","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0038-1636932","article-title":"Surgical complications after right hepatectomy for live liver donation: largest single-center western world experience","volume":"38","author":"Gorgen","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100965_bib175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijsu.2020.11.013","article-title":"Short-term and long-term outcomes in living donors for liver transplantation: cohort study","volume":"84","author":"Takagi","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib176","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.24651","article-title":"Donor safety in living donor liver donation: an Italian multicenter survey","volume":"23","author":"Lauterio","year":"2017","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib177","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.24778","article-title":"Donor safety in living donor liver transplantation: the Korean organ transplantation registry study","volume":"23","author":"Lee","year":"2017","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib178","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-6143.2009.02950.x","article-title":"Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience","volume":"10","author":"Adcock","year":"2010","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib179","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1432-2277.2010.01183.x","article-title":"Living donor liver transplantation: effect of the type of liver graft donation on donor mortality and morbidity","volume":"24","author":"Kousoulas","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib180","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/lt.20995","article-title":"Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation","volume":"13","author":"Terrault","year":"2007","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib181","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.sla.0000179646.37145.ef","article-title":"Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium","volume":"242","author":"Olthoff","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib182","article-title":"Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation","author":"Barbetta","year":"2020","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib183","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SLA.0000000000001383","article-title":"Defining long-term outcomes with living donor liver transplantation in North America","volume":"262","author":"Olthoff","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib184","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2018.12.029","article-title":"Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation","volume":"70","author":"Goldaracena","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib185","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.3112","article-title":"Evaluation of the intention-to-treat benefit of living donation in patients with hepatocellular carcinoma awaiting a liver transplant","volume":"156","author":"Lai","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib186","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/lt.26439","article-title":"National experience with living donor liver transplantation for hepatocellular carcinoma","volume":"28","author":"Silverstein","year":"2022","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib187","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/bjs.5528","article-title":"Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma","volume":"94","author":"Lo","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib188","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1600-6143.2007.01802.x","article-title":"Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation","volume":"7","author":"Fisher","year":"2007","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib189","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib191","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hbpd.2019.08.005","article-title":"Secondary non-resectable liver tumors: a single-center living-donor and deceased-donor liver transplantation case series","volume":"18","author":"Lerut","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib192","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jhep.2020.08.015","article-title":"Liver transplantation for secondary liver tumours: the difficult balance between survival and recurrence","volume":"73","author":"Line","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib193","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib194","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/tri.13391","article-title":"Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study","volume":"32","author":"Shimamura","year":"2019","journal-title":"Transpl Int"},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2023.100965_bib195","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.22356","article-title":"Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations","volume":"17","author":"Pomfret","year":"2011","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib196","first-page":"262","article-title":"A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept","author":"Line","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib197","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/SLA.0000000000002861","article-title":"Paradigm shift in the management of irresectable colorectal liver metastases: living donor auxiliary partial orthotopic liver transplantation in combination with two-stage hepatectomy (LD-RAPID)","volume":"270","author":"K\u00f6nigsrainer","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib198","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM200105243442112","article-title":"Transplantation of liver grafts from living donors into adults--too much, too soon","volume":"344","author":"Cronin","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100965_bib199","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","article-title":"Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era","volume":"254","author":"Dutkowski","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib200","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/lt.26368","article-title":"The impact of median model for end-stage liver disease at transplant minus 3 national policy on waitlist outcomes in patients with and without hepatocellular carcinoma","volume":"28","author":"Bernards","year":"2022","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib201","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2020.06.022","article-title":"Living-donor liver transplantation: right versus left","volume":"82","author":"Yagi","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/lt.25855","article-title":"A new approach for increasing availability of liver grafts and donor safety in living donor liver transplantation: LD-RAPID procedure in the cirrhotic setting with hepatocellular carcinoma","volume":"27","author":"Balci","year":"2021","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10931","article-title":"A\u00a0western world perspective of survival benefit of living donor liver transplantation: a commentary to the article by Jackson et\u00a0al. Published in JAMA Surgery","volume":"35","author":"Lai","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-3-030-63749-1_10","article-title":"Liver living donation for cancer patients: benefits, risks, justification","volume":"218","author":"Nadalin","year":"2021","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.jhepr.2023.100965_bib205","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trre.2008.02.001","article-title":"Ethical dimensions of living donation: experience with living liver donation","volume":"22","author":"Miller","year":"2008","journal-title":"Transpl Rev (Orlando)"},{"key":"10.1016\/j.jhepr.2023.100965_bib206","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/curroncol29060341","article-title":"Immunotherapy as a neoadjuvant therapy for a patient with hepatocellular carcinoma in the pretransplant setting: a case report","volume":"29","author":"Abdelrahim","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib207","doi-asserted-by":"crossref","DOI":"10.1159\/000529023","article-title":"Liver transplantation after successful downstaging of a locally advanced hepatocellular carcinoma with systemic therapy","author":"Schmiderer","year":"2023","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2023.100965_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205997","article-title":"Case report: successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy","volume":"14","author":"Chouik","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2023.100965_bib209","doi-asserted-by":"crossref","first-page":"102167","DOI":"10.1016\/j.clinre.2023.102167","article-title":"Successful advanced hepatocellular carcinoma downstaging with atezolizumab-Bevacizumab and radioembolization before liver transplantation","volume":"47","author":"Giudicelli","year":"2023","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100965_bib210","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/ajt.15617","article-title":"Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: are checkpoint inhibitors safe for the pretransplant patient?","volume":"20","author":"Nordness","year":"2020","journal-title":"Am J Transplant\u202f: official J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101386","article-title":"Pretransplant use of toripalimab for hepatocellular carcinoma resulting in fatal acute hepatic necrosis in the immediate postoperative period","volume":"66","author":"Chen","year":"2021","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jhepr.2023.100965_bib212","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/ajt.16448","article-title":"PD-1 inhibitor as bridge therapy to liver transplantation?","volume":"21","author":"Tabrizian","year":"2021","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib213","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.4049\/jimmunol.179.8.5204","article-title":"PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection","volume":"179","author":"Tanaka","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2023.100965_bib214","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jhep.2016.02.034","article-title":"Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction","volume":"64","author":"Shi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib215","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/hep.31234","article-title":"Immunotherapy as a downstaging therapy for liver transplantation","volume":"72","author":"Schwacha-Eipper","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100965_bib216","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.3390\/curroncol29120771","article-title":"Immunotherapy use prior to liver transplant in patients with hepatocellular carcinoma","volume":"29","author":"Woo","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib217","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246307","article-title":"Liver transplantation for hepatocellular carcinoma after downstaging or bridging therapy with immune checkpoint inhibitors","volume":"13","author":"Gao","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib218","article-title":"Evolving landscape in liver transplantation for hepatocellular carcinoma: from stage migration to immunotherapy revolution","volume":"13","author":"Cesario","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib219","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092056","article-title":"Immune checkpoint inhibitors as therapy to Down-stage hepatocellular carcinoma prior to liver transplantation","volume":"14","author":"Katariya","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2023.100965_bib220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/liv.15419","article-title":"Immune checkpoint inhibitors in malignancies after liver transplantation: a systematic review and pooled analysis","volume":"43","author":"Kayali","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11062","article-title":"Liver transplantation in recipients with a positive crossmatch: a retrospective single-center match-pair analysis","volume":"36","author":"Krendl","year":"2023","journal-title":"Transpl Int"},{"issue":"Suppl 2","key":"10.1016\/j.jhepr.2023.100965_bib222","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajt.16978","article-title":"OPTN\/SRTR 2020 annual data report: liver","volume":"22","author":"Kwong","year":"2022","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"},{"key":"10.1016\/j.jhepr.2023.100965_bib223","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2023.01.030","article-title":"Liver transplantation immunology: immunosuppression, rejection, and immunomodulation","volume":"78","author":"Montano-Loza","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100965_bib224","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.21037\/jgo-22-922","article-title":"Immune checkpoint inhibitors in liver transplant: a case series","volume":"14","author":"Rudolph","year":"2023","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/TP.0000000000002147","article-title":"International liver transplantation society consensus statement on immunosuppression in liver transplant recipients","volume":"102","author":"Charlton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib226","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12072-020-10091-5","article-title":"Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group","volume":"14","author":"Cillo","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100965_bib227","first-page":"1227","article-title":"Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria","volume":"86","author":"Fan","year":"2006","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jhepr.2023.100965_bib228","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00432-009-0584-6","article-title":"Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China","volume":"135","author":"Fan","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhepr.2023.100965_bib229","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/lt.21281","article-title":"Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation","volume":"13","author":"Ito","year":"2007","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib230","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/01.tp.0000259015.46798.ec","article-title":"Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma","volume":"83","author":"Soejima","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib231","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","article-title":"Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series","volume":"25","author":"Sugawara","year":"2007","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2023.100965_bib232","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.21484","article-title":"Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma","volume":"14","author":"Toso","year":"2008","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib233","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","article-title":"Liver transplantation for hepatocellular carcinoma: Hangzhou experiences","volume":"85","author":"Zheng","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100965_bib234","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/lt.21445","article-title":"Expanded indication criteria of living\u00a0donor liver transplantation for hepatocellular carcinoma at one large-volume center","volume":"14","author":"Lee","year":"2008","journal-title":"Liver Transplant: Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jhepr.2023.100965_bib235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/SLA.0b013e31820508f1","article-title":"Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion","volume":"253","author":"DuBay","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib236","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for\u00a0hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100965_bib237","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s11605-013-2140-6","article-title":"Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies","volume":"17","author":"Lei","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100965_bib238","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","article-title":"Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria","volume":"8","author":"Ravaioli","year":"2008","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surgeons"}],"updated-by":[{"DOI":"10.1016\/j.jhepr.2024.101071","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T03:04:49Z","timestamp":1711767889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":238,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2589555923002963"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100965","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplant oncology \u2013 Current indications and strategies to advance the field","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100965"}}